FDA

The FDA adds n-methyltyramine and octopamine to its advisory list

The FDA adds n-methyltyramine and octopamine to its advisory list

FDA introduces a tool to alert the public about unlawful ingredients

FDA introduces a tool to alert the public about unlawful ingredients

The FDA issues warning letters regarding DMHA and phenibut

The FDA issues warning letters regarding DMHA and phenibut

FDA commissioner issues a statement regarding supplement regulation

FDA commissioner issues a statement regarding supplement regulation

FDA now considers high caffeine bulk supplements unlawful

FDA now considers high caffeine bulk supplements unlawful

New study published on stimulants structurally similar to DMAA

New study published on stimulants structurally similar to DMAA

The FDA issues a warning against the use of SARMs

The FDA issues a warning against the use of SARMs
Fight fat with fire - NOVALEAN - Now available! »